Binding of basic fibroblast growth factor (bFGF) to the extracellular matrix of cultured bovine aorta smooth muscle cells is likely to be mediated via heparan sulphate, since not only exogenous addition of heparan sulphate to the culture medium but also pretreatment of the cells with heparitinase (but not chondroitinase ABC) resulted in loss of binding. Comparison of the affinity of bFGF to various glycosaminoglycan-conjugated gels showed a direct and specific binding of bFGF to heparan sulphate. Heparan sulphate also bound to a bFGF affinity gel. However, the proportion of heparan sulphate bound varied depending on the source of the HS (more than 90 % and 45 % with pig aorta heparan sulphate and mouse EHS tumour heparan sulphate respectively). The bound heparan sulphate had the ability to protect bFGF from proteolytic digestion, but the unbound heparan sulphate did not. The results suggest the presence in the bound heparan sulphate of a specific structure involved in binding. Limited digestion with heparitinase I of porcine aorta heparan sulphate yielded 13 % oligosaccharides bound to the gel, of which the smallest were octasaccharides. Analysis of a hexadecasaccharide fraction which was obtained at the highest yield among the bound oligosaccharides was performed by h.p.l.c. of the deamination products obtained with nitrous acid and the unsaturated disaccharide products formed by heparitinase digestion. Comparison of the disaccharide unit compositions exhibited a marked difference in IdoA(2SO4)GlcNSO3 and IdoA(2SO4)GlcNSO3(6SO4) units between the bound and unbound hexadecasaccharides. The amounts measured were 3 mol and 1 mol per mol of the former and 0.4 mol and 0.6 mol per mol of the latter. It is likely that the binding of bFGF to heparan sulphate may require the domain structure of the heparan sulphate to be composed of clustering IdoA(2SO4)-GlcNSO3 units.
INTRODUCTION
A large body of evidence indicates that many types of proteoglycans are involved in the regulation of cell growth. For example, the cell-surface heparan sulphate proteoglycan isolated from post-confluent cultures ofaorta smooth muscle cells exhibits a potent inhibition of cell growth [1] . The heparan sulphate isolated from the surfaces of rat hepatocytes, when added to culture medium, inhibits the growth of hepatocytes where heparan sulphate enriched with GlcA(2S04)GlcNSO3(6S04) units appeared in the nucleus [2, 3] . Epidermal growth factordependent proliferation of aorta smooth muscle cells was also regulated by heparan sulphate, perhaps owing to the interaction with thrombospondin [4] .
Basic fibroblast growth factor (bFGF) is a potent mitogen that stimulates proliferation and differentiation of various types of mesenchymal and neuroectodermal cells, thereby mediating various biological processes such as wound repairing, angiogenesis and neurite outgrowth [5, 6] . bFGF binds strongly to heparin, and this property has greatly facilitated the purification and characterization of bFGF [7] . It has also been shown that bFGF may bind to heparan sulphate proteoglycans in the extracellular matrix (ECM) formed by cultured cells such as vascular and capillary endothelial cells [8] [9] [10] , and to heparan sulphate proteoglycans in their plasma membranes [11] . Immunohistochemical studies have revealed bFGF deposition in the basement membranes and ECM of a variety of tissues of which heparan sulphate proteoglycans are the major constituents [12] [13] [14] . Thus bFGF is likely to be stored and stabilized by binding to the heparan sulphate proteoglycans in the ECM and basement membranes. More recently, Yayon et al. [15] and Rapraeger et al. [16] have suggested that the binding of bFGF to its high-affinity receptor requires its binding to heparan sulphate or heparin. The three-dimensional structure of bFGF induced by heparan sulphate binding has been suggested to be important for the interaction between bFGF and the receptor [17] .
In the present study we have isolated heparan sulphate oligosaccharides capable of binding to bFGF, and analysed products of these oligosaccharides produced by deamination cleavage with nitrous acid and digestion with heparinase and heparitinases. The results suggest that the binding may be dependent upon specific sugar sequences and sulphation patterns in heparan sulphate. We (12. 3 Ci)/mmol in 0.1 M-NaOH] were purchased from Amersham Japan, Tokyo, Japan. Heparan sulphates from pig aorta and EHS tumour, chondroitin 6-sulphate from shark cartilage, dermatan sulphate from pig skin, chondroitin sulphate E from squid cartilage, chondroitin 4-sulphate from whale cartilage and hyaluronic acid were obtained from Seikagaku Corporation, Tokyo, Japan. Porcine intestinal mucosa heparin and trypsin (type III) were purchased from Sigma Chemical Co., St. Louis, MO, U.S.A. Heparitinases I, II and IV, heparinase and chondroitinase ABC were from Seikagaku. Ready-safe scintillant was from Beckman, Palo Alto, CA, U.S.A. X-ray film (AIF RX) was from Fuji Photo Film Co., Tokyo, Japan. Rainbow protein Mr markers were from Amersham Japan, Tokyo, Japan. Epoxy-activated Sepharose 6B, CNBr-activated Sepharose 4B, Sepharose 6B and Sephadex G-50 were from Pharmacia, Uppsala, Sweden.
[3H]Tetrasaccharide and [3H]octasaccharide prepared from testicular hyaluronidase digests of chondroitin [18] were gifts from Dr. 0. Habuchi, Aichi Kyoiku University.
Cell culture
Smooth muscle cells were obtained by culturing explants of bovine aorta as described by Ross [19] . Cells were subcultured in Dulbecco's Modified Eagle's medium (DMEM) containing 10 % (v/v) fetal calf serum (FCS), penicillin and streptomycin at 37°C in a humidified 5 % CO2 atmosphere. SMC in the sixth passage were used for the experiments.
Preparation of ECM from cultured bovine aorta smooth muscle cells and 125I-bFGF binding to the ECM Bovine aorta smooth muscle cells (2 x 104) were seeded on to 16 mm wells and grown to post-confluency. The cell layer was washed with phosphate-buffered saline [PBS(-)] and treated with 0.5 % (w/v) Triton X-100 in PBS(-) at 37°C for 30 min with shaking. The residual cell layer was washed with PBS(-) four times. ECM thus prepared was incubated with 125I-bFGF for 60 min at room temperature with gentle shaking. After four washes with PBS(-), the radioactivity of 125I-bFGF bound to ECM was counted in a y-radiation counter.
Preparation of glycosaminoglycan (GAG)-conjugated Sepharose gels GAG-Sepharose gels were prepared by the reported method with a minor modification [20] . 3-Amino-2-hydroxypropyl-derivatized Sepharose gels were prepared from epoxy-activated Sepharose 6B gels according to the method recommended by the manufacturer. Portions of 3 g of amino-Sepharose gels thus obtained were suspended in 3 ml of 0.2 M-phosphate buffer, pH 7.2, containing 90 mg of GAG and 9 mg of NaBH3CN. The suspension was kept at room temperature for 48 h with gentle shaking. The gels were washed several times with PBS(-). The amount of immobilized GAG was about 1.8-3.7 mg/ml of gel. 200 ,ug of chondroitin 6-sulphate/ml (solution B) was applied to a syringe column of bFGF-Sepharose (0.5 ml) equilibrated with solution B at 4°C, and the column was shaken gently for 2 h. The column was then washed with 10 ml of solution B and eluted with a linear gradient from 0 to 3 M-NaCl in solution B at 5 ml/h. 3H-labelled or unlabelled oligosaccharides were subjected to affinity chromatography as described above, except that a stepwise elution method was used. The eluates containing chondroitin 6-sulphate were desalted using a Fast desalting column (Pharmacia) and then digested with chondroitinase ABC [21] . After digestion, heparan sulphate was recovered by ethanol precipitation, and for separation of oligosaccharides the digests were directly subjected to gel filtration. 2 h. As far as we could ascertain, heparan sulphate preparations used in this study were depolymerized to disaccharides with 96-98 % yields under the above digestion conditions. The yields were determined by comparing the relative proportions of the hexuronic acid content corresponding to disaccharides recovered by gel permeation with those in the starting preparations. The unsaturated disaccharide products were analysed by h.p.l.c. using a polyamine-bound silica PAMN column (YMC). The elution was performed by a linear gradient from 40 mM-to 550 mM-KH2PO4, and a subsequent elution with 550 mm-KH2PO4 at a flow rate of 1.5 ml/min at 40 'C. The elution was monitored by u.v. absorption at 232 nm. Each peak was identified by comparison of its retention time with those of standard unsaturated disaccharides, as described previously [22] .
Degradation of the saccharides with nitrous acid at pH 1.5 and reduction of the products with [3H]NaBH4 were carried out as described by Shively & Conrad [23] . The products were subjected to gel chromatography using an HW40S column (98 cm x 1.6 cm) (Toso Co., Tokyo, Japan) which had been equilibrated with 0.5 M-NH4HCO3. The fractions corresponding to labelled disaccharides were collected and analysed by h.p.l.c. on a Partisil-10 SAX column (Whatman, Clifton, NJ, U.S.A.) as described by Bienkowski & Conrad [24] . The elution was monitored by measuring the radioactivity in a liquid scintillation counter.
Determination of oligosaccharide size
For determination of molecular size, oligosaccharide samples were chromatographed on a Sephadex G-50 column 2)/0.15 M-NaCI/0.4 mM-MgCl2/0.9 mM-CaC12J. GAG (0-10 ,ug) was added to the above reaction mixture. After shaking at 37°C for 5 min, 5 ,1 ofO.1 % (w/v) trypsin was added and the mixtures were incubated at 37°C for I or 3 h. Aliquots of the digests were analysed by SDS/PAGE in a 20 % gel [25] . The gels were dried and exposed at -80°C to X-ray film for 2 days. To the remaining digests were added 100 ,tg of BSA and 10 % (final concentration) cold trichloroacetic acid. The precipitates were centrifuged at 12100 g for 30 min at 4 'C. The radioactivity in the supernatants was measured to determine the extent of degradation of 1251-bFGF.
The activity of trypsin was determined by measuring the increase in absorbance at 410 nm using Bz-DL-Arg-p-nitroanilide as a substrate. 200 ,ug of chondroitin 6-sulphate/ml (solution B) and applied to a bFGF-Sepharose column (0.5 ml) equilibrated with solution B. After standing at 4°C for 2 h with gentle shaking, the column was washed with 10 ml of solution B, and then eluted with a 0-3 M-NaCl gradient in PBS( +) at 4 ml/h. Fractions (1 ml/tube) were collected and analysed for radioactivity. Fractions 1-5 and 12-27 from EHS tumour heparan sulphate were pooled, desalted, and concentrated (referred to as unbound HS and bound HS respectively) for further analyses.
Sepharose gels and their affinity interaction with 125I-bFGF was examined ( Table 2 ). The radioactivity was specifically bound to the heparan sulphate-or heparin-conjugated gels, but not to gels conjugated with hyaluronic acid, chondroitin 4-sulphate or dermatan sulphate. Since the net negative charge contributed by sulphate of heparan sulphate (0.42/disaccharide) is apparently lower than that ofchondroitin 4-or 6-sulphate (1.0/disaccharide) or chondroitin sulphate E (1.7/disaccharide), the results in Tables  1 and 2 indicate that the binding of bFGF to heparan sulphate is not simply due to an electrostatic interaction. Separation of heparan sulphate species with different affinities for bFGF When 3H-labelled heparan sulphate from pig aorta was applied to a column of bFGF-conjugated Sepharose equilibrated with PBS(+) containing 200,tg of chondroitin 6-sulphate/ml (solution B; chondroitin 6-sulphate was included to prevent nonspecific binding), more than 900% of the starting radioactivity was retained on the column. Subsequent elution with a linear salt gradient from 0 to 3 M-NaCl in PBS(+) recovered most of the bound heparan sulphate from the column, with a peak at 0.6 MNaCi (Fig. 1) . In contrast, about 540% of 3H-labelled EHS tumour heparan sulphate appeared in the washings with solution Fig. 3) [3H]NaBH4 and applied to a bFGF-conjugated Sepharose gel column equilibrated with solution B. After washing with solution B, the column was eluted with 2 M-NaCl in PBS( +) as described above (Fig. 2a) . About 13 % of the applied radioactivity was bound to the bFGF column. When the bound and unbound oligosaccharide fractions were re-chromatographed on the same bFGF-Sepharose column, the unbound fraction did not yield any bound radioactivity, and most radioactivity from the bound fraction was reproducibly retained (Fig. 2b) . These oligosaccharide fractions will be referred to subsequently as unbound oligo and bound oligo respectively.
Characterization of bound oligo and unbound oligo
Bound oligo and unbound oligo were subjected to gel chromatography on Sephadex G-50 (Fig. 3) . Bound oligo was eluted between VO and the position of octasaccharides, with a peak at K,V = 0.25, corresponding to octadeca-or hexadeca-saccharides (Mr 3700-4000). In contrast, unbound oligo showed a broad distribution with a peak around the position of hexasaccharides. It should be noted that, although the distribution of unbound oligo overlapped with that of bound oligo, oligosaccharides smaller in size than hexasaccharides were only detected in unbound oligo. The results suggest that octasaccharides are the minimal size required for the binding of bFGF, and that a factor other than chain length is also involved in bFGF binding.
[3H]Hexadecasaccharides from bound oligo and unbound oligo were separately pooled (fractions 58-60; shaded bar in Fig. 3 ), since oligosaccharides of this size formed the majority in bound oligo. Both fractions were subjected to further fractionation by ion-exchange chromatography on a Mono Q column (Fig. 4) . Most of the bound hexadecasaccharides were eluted in a single peak at 0.7 M-NaCl (fractions 22-34; termed B16-H in Fig. 4) . On the other hand, the unbound hexadecasaccharides were eluted broadly with at least two major peaks at 0.3 M-and 0.7 M- Fig. 4 . The analysis was performed as described in Table 3 . Unidentified disaccharides represented less than 5 %/ of the total.
Composition (% of total) The approximate molar ratios of the disaccharides per mol of B16-H were estimated from the data in Table 4 . The sample was also incubated at 37°C for 1 h without trypsin (lane 1). Aliquots of the digests were subjected to SDS/PAGE (20% gel). After drying, the gel was exposed to an X-ray film. The positions of standard proteins are indicated by the arrowheads.
NaCl. About 30 % of the starting unbound hexadecasaccharide was recovered in the 0.7 M-NaCl fraction (fractions 22-34, termed U16-H in Fig. 4) . The results show that the difference in bFGF affinity between B16-H and U16-H cannot be accounted for by a difference in the net negative charge alone. B16-H and U16-H were exhaustively digested with a mixture of heparitinase I, heparitinase II and heparinase. The digested products were subjected to compositional analyses by h.p.l.c. on a polyamine silica column with a linear gradient elution of KH2PO4. Comparison of the disaccharide compositions of B 16-H and U 16-H revealed a marked difference (Table 4) : 470% of the disaccharides obtained from the former were 2-0-sulphated hexuronic acid-containing disaccharide units [ADi-(N,U)diS plus ADi-(N,6,U)triS], whereas only 140% were 2-0-sulphated in the latter. When the dodecasaccharide fraction from bound oligo (cf. Fig. 3 ) was subjected to compositional analysis as above, about 50 % of the disaccharides were 2-0-sulphated (results not shown).
No further analysis has been done with this fraction, owing to the small amount available.
To identify the hexuronic acid residues participating in bFGF binding, B16-H was treated with nitrous acid at pH 1.5 ---S 0_
Experimental section. Of the total labelled saccharides, 58 % were recovered in the disaccharide fraction, 21 % were in the tetrasaccharide fraction, and the remainder were in the hexasaccharide or larger oligosaccharide fractions (results not shown). The disaccharide fraction was then subjected to h.p.l.c. on a SAX column with stepwise elution with increasing concentrations of KH2PO4 (Fig. 5) . More than 90% of the major disaccharide products [HexUA(2SO4)AManR and HexUA(2SO4)AManR(6-SO04)] were of iduronic acid (IdoA)-type (compare peak 2 with peak 5 and peak 7 with peak 8 in Fig. 5 ). In contrast, most of the minor disaccharide fractions [HexUAAManR(6SO4) etc.] were of the GlcA type (Fig. 5, compare peak 3 with peak 4) . The nonreducing end of B16-H should be non-sulphated unsaturated hexuronic acid, considering both the substrate specificity and catalytic properties of heparitinase I. If the penultimate glucosamine residue is N-acetylated, the deamination products from the non-reducing end should be tetrasaccharides or larger oligosaccharides with unsaturated hexuronic acid at the non-reducing terminal. If, however, the penultimate glucosamine residue is Nsulphated, the products should be disaccharide derivatives with unsaturated hexuronic acid. Although the chromatographic behaviours of such unsaturated disaccharides are not known, there is a possibility that some minor peaks in Fig. 5 represent such disaccharides. Molar ratios of the disaccharides (per mol of B16-H) estimated from the results of Table 4 and Fig. 5 are shown in Table 5 . The characteristically high proportion of 2-0-sulphated iduronic acid-containing disaccharide units (4 (Fig. 6) . To compare the protective abilities of various GAGs quantitatively, the remaining portions of the digests were precipitated with 10% cold trichloroacetic acid, and radioactivity in the supernatants was measured as described in the Experimental section. The relative protective abilities of GAGs against tryptic digestion are expressed as the concentrations of GAGs causing 50 % inhibition of 1261-bFGF Table 6 ). The unfractionated heparan sulphate was more than 100 times as active as chondroitin 6-sulphate. Further, bound HS was 50 times more active than unbound HS. None of the heparin and heparan sulphate preparations used inhibited the protease activity itself when Bz-DL-Arg-p-nitroanilide was used as a substrate. The results are consistent with the idea that bFGF-bound heparan sulphate may contain some specific structural units for binding to bFGF, thereby directly influencing the stability of bFGF.
DISCUSSION
The present studies have shown that heparan sulphates are separated into two types with distinctive high or low affinity for bFGF; the ratio of the two varies with different preparations of heparan sulphate (Fig. 1) . This suggests that expression of binding sites for bFGF on heparan sulphates may be regulated, depending upon differences in cell types, cell growth phase and cell transformation.
Hexadecasaccharides which were derived from pig aorta heparan sulphate by limited digestion with heparitinase I and which bound to bFGF gels characteristically comprised 3 mol of IdoA(2SO4)GlcNSO3 and 1 mol of IdoA(2SO4)GlcNSO3(6SO4) per molecule (Table 5 ). In addition, about 50% of the disaccharide units in the dodecasaccharides bound to the gels were IdoA(2SO4)-containing units (3 mol per molecule). These results, and the fact that the octasaccharides were the smallest fragments for binding of bFGF and that their non-reducing ends were nonsulphated unsaturated hexuronic acid, suggest that clustering of three IdoA(2SO4)-containing disaccharide units appears to form the site in heparan sulphate for the binding of bFGF. In relation to this structural requirement, it should be noted that the minimal structure of heparin required for acidic (a)FGF binding is [IdoA(2SO4)GIcNSO3(6SO4)]3 [26] , which suggests the existence of common structural features for the binding of the FGF family growth factors.
Evidence for the clustering of IdoA(2SO4)-containing disaccharide units were also obtained by taking advantage of the specificity of heparitinase IV. Since this enzyme can only cleave glycosaminidic linkages to 2-0-sulphated iduronic acid residues of heparan sulphates, unsaturated disaccharide products would be produced only from these clusters. In fact, digestion of pig aorta heparan sulphate with heparitinase IV released two-thirds of the total IdoA(2SO4)GlcNSO3 units and half of the total IdoA(2SO4)GlcNSO3(6SO4) units as unsaturated disaccharide products (results not shown). Furthermore, in view of the conformational versatility of IdoA or IdoA(2SO4) residues in heparan sulphates [27, 28] , it is tempting to assume that the Vol. 285 domains rich in these residues may be flexible enough to fit the binding site of bFGF. The clustering structure of two or three disaccharide units of IdoA(2SO4)GlcNSO3 and/or IdoA(2S04)GlcNSO3(6S04) has already been shown to occur in heparan sulphates from cultured skin fibroblasts, although their ability to bind to bFGF has not been tested [29] .
Since we observed that the bound fraction of heparan sulphate from pig aorta had an Mr of 47000 and its IdoA(2S04)GlcNSO3 [30] . Therefore clustering of IdoA(2S04)-containing disaccharide units appears to be important for functions of both heparan sulphate and dermatan sulphate, and may be regulated by similar biosynthetic mechanisms in which hexuronosyl 5-epimerase and iduronosyl 2-0-sulphotransferase take a part [31] [32] [33] [34] .
Suggested biological roles of the interaction between bFGF and heparan sulphate are as follows. (1) The interaction enables bFGF to accumulate in the ECM [8, 10] and protects bFGF from proteolysis (Fig. 6, Table 6 ; see [35] [36] [37] ). (2) The binding of bFGF to heparan sulphate is necessary for the interaction of bFGF with its high affinity receptor [15, 16] . A three-dimensional conformation change may occur in the receptor-binding domain of bFGF so as to make it accessible to the receptor [38] [39] [40] . The FGF bound to heparan sulphate proteoglycan in both the ECM and the cell surface could be released by attack with heparitinase [41] and/or proteases [36] as diffusible FGF-heparan sulphate oligosaccharide complexes [42] . For example, heparitinase from platelet cleaves a GIcA site of GlcAGlcNS03 [43] which may be localized outside the FGF-binding domain, and the bFGFheparan sulphate oligosaccharide complex thus formed could diffuse freely to the FGF receptor.
It has been shown that bFGF is transported from the cell surface to the nucleus by endocytosis via endosomes and lysosomes [44] . Interestingly, heparin is also translocated into the nucleus [45] . Furthermore, heparan sulphate enriched in GIcA(2S04)GlcNS03(6S04) has been found in the nuclei of rat hepatoma cells [2] . Therefore it is possible that bFGF-heparan sulphate oligosaccharide complexes are internalized by FGFreceptor-mediated endocytosis and transported into the nucleus under protection against proteolysis.
aFGF also binds to heparin and heparan sulphate [5, 46] , and exhibits 55 % sequence identity with bFGF [47] . Both aFGF and bFGF have similar cell growth activity on a wide range of cultured cells, although their locations are different from each other in various tissues [5, 6] . Further, the interaction between aFGF and heparin/heparan sulphate has also been shown to protect the mitogenic activity ofaFGF against proteolysis [35, 48] . In our preliminary work, the bound HS fraction also protected against the proteolytic inactivation of aFGF, but unbound HS did not. These data suggest that the aFGF-binding domain of heparan sulphate may be shared, at least in part, with the one for bFGF. Numerous studies have revealed that heparin binds various kinds of growth factors and ECM components (e.g. see
